REG - Dr. Martens PLC - Result of AGM

Dr MartensAnnouncement

11/07/2024 11:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240711:nRSK0617Wa&default-theme=true

RNS Number : 0617W  Dr. Martens PLC  11 July 2024

11 July 2024

DR. MARTENS PLC

RESULT OF ANNUAL GENERAL MEETING

11 JULY 2024

 

The Company announces the results of voting at its Annual General Meeting held
earlier today and confirms that all resolutions were duly passed on a poll
with majorities as set out below.

Resolutions 1 to 16 were proposed as Ordinary Resolutions and resolutions 17
to 20 as Special Resolutions.

 Resolution                                                                      Votes        %       Votes Against  %      Votes        Votes Withheld  % Voting

For

Total

                    (note 1)
            (note 2)        Capital Instructed

                                                                               (note 1)

 01      Receive the 2024 Annual Report and Accounts                             789,653,948  99.87%  1,016,107      0.13%  790,670,055  389,119         82.18
 02      Approve the Directors' Remuneration Report                              784,551,256  99.18%  6,479,754      0.82%  791,031,010  28,164          82.22
 03      Approve the Remuneration Policy                                         784,540,438  99.18%  6,484,634      0.82%  791,025,072  34,102          82.22
 04      Approve the Final Dividend                                              790,899,254  99.98%  138,398        0.02%  791,037,652  21,522          82.22
 05      Elect Giles Wilson                                                      790,575,687  99.94%  472,252        0.06%  791,047,939  11,235          82.22
 06      Re-elect Paul Mason                                                     739,380,746  98.45%  11,649,105     1.55%  751,029,851  40,029,322      78.06
 07      Re-elect Kenny Wilson                                                   782,546,350  99.38%  4,857,639      0.62%  787,403,989  3,655,185       81.84
 08      Re-elect Andrew Harrison                                                784,035,245  99.11%  7,011,325      0.89%  791,046,586  12,587          82.22
 09      Re-elect Ian Rogers                                                     784,033,188  99.11%  7,013,122      0.89%  791,046,586  12,587          82.22
 10      Re-elect Lynne Weedall                                                  782,969,980  98.98%  8,079,606      1.02%  791,049,586  9,587           82.22
 11      Re-elect Robyn Perriss                                                  783,169,527  99.00%  7,880,059      1.00%  791,049,586  9,587           82.22
 12      Re-elect Tara Alhadeff                                                  775,890,657  98.53%  11,583,929     1.47%  787,474,586  3,584,587       81.85
 13      Re-appoint PricewaterhouseCoopers LLP as auditor                        790,431,574  99.92%  619,491        0.08%  791,051,065  8,109           82.22
 14      Authorise the Audit & Risk Committee to determine the Auditor's         790,886,095  99.98%  160,465        0.02%  791,046,560  12,614          82.22
         remuneration
 15      Authorise the Company and its subsidiaries to make political donations  782,418,912  99.36%  5,046,388      0.64%  787,465,300  3,593,874       81.85
 16      Authorise allotment of shares                                           781,095,005  99.30%  5,488,607      0.70%  786,583,612  4,475,562       81.76
 17      Authorise general disapplication of pre-emption rights*                 744,775,869  94.58%  42,685,045     5.42%  787,460,914  3,598,260       81.85
  18     Authorise additional disapplication of pre-emption rights*              743,752,064  94.45%  43,708,850     5.55%  787,460,914  3,598,260       81.85
 19      Authorise purchase of own shares*                                       772,052,557  97.61%  18,934,341     2.39%  790,986,898  72,276          82.22
 20      Authorise calling of general meetings on 14 days' notice*               788,373,014  99.66%  2,680,102      0.34%  791,053,116  6,058           82.22

*Special Resolution

 

The votes of independent shareholders on the resolutions concerning the
election or re-election of the Independent Non-Executive Directors are set out
below:

 Resolution                        Votes        %       Votes Against  %      Votes        Votes Withheld  % Independent

For

Total

                            Capital Instructed

 08      Re-elect Andrew Harrison  414,092,821  98.34%  7,011,325      1.66%  421,104,146  12,587          71.12%
 09      Re-elect Ian Rogers       414,091,024  98.33%  7,013,122      1.67%  421,104,146  12,587          71.12%
 10      Re-elect Lynne Weedall    413,027,540  98.08%  8,079,606      1.92%  421,107,146  9,587           71.13%
 11      Re-elect Robyn Perriss    413,227,087  98.13%  7,880,059      1.87%  421,107,146  9,587           71.13%

 

Notes:

1.     Votes "For" and "Against" are expressed as a percentage of votes
received.

2.    A "Vote withheld" is not a vote in law and is not counted in the
calculation of the votes "For" or "Against" a resolution.

3.    As at 6.30pm on 9 July 2024 the Company had a total of 962,080,090
ordinary shares with voting rights in issue. The total independent voting
capital, used to calculate the votes of independent shareholders on
resolutions 8 to 11, was 592,062,882.

4.     In accordance with Listing Rule 9.6.2R, copies of the resolutions
passed as special business will shortly be available for inspection on the
National Storage Mechanism at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

Enquiries

Company Secretariat

Paul Rolling, Assistant Company Secretary
 
+44 7584 243562

 

Investors and analysts
 

Bethany Barnes, Director of Investor Relations
                                        +44 7825 187465

 
 
                                 bethany.barnes@drmartens.com
(mailto:bethany.barnes@drmartens.com)

Media
 

Gill Hammond, Director of Communications
                                       +44 7384 214248

 

H/Advisors Maitland
 
           +44 20 7379 5151

Katharine Spence
 
              +44 7384 535739
 

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire.
Produced originally for workers looking for tough, durable boots, the brand
was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens has since transcended its working-class roots while
still celebrating its proud heritage and, six decades later, "Docs" or "DM's"
are worn by people around the world who use them as a symbol of empowerment
and their own individual attitude. The Company is a constituent of the FTSE
250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGGPUCUMUPCGUG